Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic ...

NAPLES, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Varian Biopharmaceuticals, Inc. (“Varian Bio”), a private, precision oncology company developing novel therapeutics for the treatment of cancer ...

Cynthia Ozick, in her review of Julie Orringer’s novel “The Flight Portfolio” (May 5), ends with a warning: “Orringer’s Varian is movie-tone make-believe. Do not mistake him for Varian ...

Varian’s revenues, meanwhile, are expected to produce growth in the low teens compared to the latter half of this past fiscal year and weigh in at about €3 billion, or about $3.4 billion.

PALO ALTO, Calif.--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, announced a U.S. co-marketing and sales agreement with Embolx for the sale and market development of the Sniper Balloon ...

Shares up 4.8% Raises Varian synergy targets Group revenue to grow 6%-8% between 2023 and 2025 BERLIN, Nov 17 (Reuters) - Shares in Siemens Healthineers (SHLG.DE), opens new tab rose on Wednesday ...

However, Siemens Healthineers lowered its profit margin outlook for Varian due to "temporary challenges in outbound logistics" at its U.S. maker of devices and software for treating cancer to 14 ...

As any engineer can attest, the triangle is the strongest shape, and Varian Medical Systems, Adaptiiv Medical Technologies and HP have formed one of their own to take on the daunting task of ...